Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc., as indicated in the metadata) on February 15, 2013, regarding events occurring on February 12, 2013. The filing discloses a presentation made by company representatives at the 15th Annual BIO CEO & Investor Conference in New York City.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a regulatory communication event and does not contain financial statements or performance data.
Material Changes
No material financial changes versus prior periods are reported in this document. The filing is limited to the disclosure of conference presentation slides under Regulation FD.
Guidance, Outlook, and Risks
The filing includes slides from the February 12, 2013 conference as Exhibit 99.01. The text explicitly states that the information contained in this report and its exhibits is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated. No specific guidance, outlook, or risk factors are detailed within the body of this 8-K text.
Investor Verification Checklist
- Verify the company name is Neuralstem, Inc., not Palisade Bio, Inc.
- Review Exhibit 99.01 (the conference slides) for any forward-looking statements or operational updates not summarized in the 8-K text.
- Confirm that no financial data is embedded in this specific filing; refer to the most recent 10-K or 10-Q for financial metrics.
- Note the filing date (February 15, 2013) versus the event date (February 12, 2013).